PGNY
Progyny Inc
NASDAQ: PGNY · HEALTHCARE · HEALTHCARE PLANS
$22.55
+1.49% today
Updated 2026-06-05
Market cap
$2.09B
P/E ratio
34.58
P/S ratio
1.61x
EPS (TTM)
$0.77
Dividend yield
—
52W range
$16 – $29
Volume
1.5M
Progyny Inc (PGNY) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$22.55
12-Month target
$18.09
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.5B | $0.8B | $1.1B | $1.2B | $1.3B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 5.24%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.